Navigation Links
Minimally Invasive Surgery Fixes Aneurysms
Date:1/30/2008

or conventional surgery. And 95 percent of those having EVAR went home from the hospital rather than to a rehabilitation facility or nursing home, compared to 80 percent of people having conventional surgery, Schermerhorn said.

"If the anatomy is good, EVAR is worth considering for any age group," Schermerhorn said. The length of the aorta beneath the arteries to the kidneys must be long enough to allow the procedure, he added.

Dr. Roy Greenberg, director of endovascular research at the Cleveland Clinic, said the new study confirms "what other trials have already shown us."

However, the new study has some shortcomings that partially offset the advantage offered by such a large database, Greenberg said. The major disadvantage is that it lumps together a very diverse group of cases, "comparing patients that are not easily comparable," he explained.

"We do an intervention in these cases not because the aneurysm is bothering patients but because we believe it will prolong patients' lives," he said. "The real question is, are we prolonging patients' lives, and we can't get an answer from this data set. There are too many compounding factors."

Still, the new report "does point out the pros and cons that are very important when we talk to patients about a procedure," Greenberg said.

Dr. Joseph Coselli, chief of adult cardiac surgery at the Texas Heart Institute, concurred that the new research confirms the short-term benefits of EVAR, at least for older patients.

"The mortality rate is lower, morbidity is clearly lower and hospitalization time, blood requirements and the ability to return home or to work are certainly less than with open surgery," he said.

But some issues haven't been completely resolved, Coselli said. "Durability of EVAR is still up in the air," he said. "And there still is a group of patients on the younger end that may yet, based on current technology, require an open operat
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Published Results Using AtriCure Minimally Invasive Products
4. Awake the Movie Highlights the Need for Goldilocks Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R)
5. Z-shaped incision enhances minimally-invasive surgery
6. Z-shaped incision enhances minimally invasive surgery
7. Less invasive lymph node biopsy method could spare thousands unnecessary operations
8. Noninvasive tests for cirrhosis may help to avoid liver biopsy
9. UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting
10. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
11. Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Minimally Invasive Surgery Fixes Aneurysms
Minimally Invasive Surgery Fixes Aneurysms
(Date:12/16/2009)... HOUSTON, Dec. 16 OrthoAccel Technologies, Inc., ... is an acceleration device to enhance orthodontics, announced ... in the UK. Ms. Davies has spent ... in the dental industry, most recently for nine ... Technology , makers of Invisalign . ...
(Date:12/16/2009)... 16 New research published online, ... in pistachios, and molecules present in pistachios, ... decreases levels of an inflammatory marker known ... 2). Inflammation is a complex biological response ... irritants, and it underlies functional changes associated ...
(Date:12/16/2009)... Dec. 16 Quantros, Inc., a leading ... services solutions for the healthcare industry, announces the ... Quantros has named software industry veteran Michael Tulloch, ... will work from the company,s new Marlborough, MA ... a natural one," explains Tulloch. "Quantros has been ...
(Date:12/16/2009)... (BUSM) Pulmonary Center has received a two-year $1.4 ... Blood Institute to derive stem cells and lung ... Darrell Kotton, MD, associate professor of medicine and ... of medicine, are the principal investigators of this ... a multicenter investigative team of five Boston University ...
(Date:12/16/2009)... strongly indicates that wellness programs have a positive impact on ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... of employers have improved employee participation in health and wellness ... survey, conducted by Hallmark Insights, a leader in incentive-driven health ...
Breaking Medicine News(10 mins):Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2
... blunt, non-penetrating hit to the chest from a baseball or hockey puck ... The condition, commotio cordis and its prevention were investigated in the March/April ... ... February 24, 2009 -- A blunt, non-penetrating hit to the chest from ...
... among women is associated with a statistically significant increase in ... the cancers of the breast, liver, rectum, and upper aero-digestive ... online issue of the Journal of the National Cancer ... has been known about the impact of low to moderate ...
... reduces the long-term risk of disease recurrence and deaths ... not take tamoxifen, according to trial data reported in ... of the National Cancer Institute. , Systematic reviews ... reduce the risk of disease recurrence and death due ...
... sent to a cardiologist to go through a standard battery ... of coronary artery disease which is the most common cause ... men, and these women are sent home with little more ... of similar symptoms and are more likely to develop future ...
... Diagnosing acute stroke is a high-pressure decision. The speed ... Early treatment can stop brain damage, but if treatment ... of bleeding in the brain. , Because of this ... enzyme known as tissue plasminogen activator (tPA)is usually reserved ...
... Mass. (Feb 23, 2009) Postpartum depression is a ... of new mothers. Some of the causes might include ... of social, financial or emotional support. Left untreated, it ... mother but on her child,s development. , ...
Other Medicine News:Health News:Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes 2Health News:Million women study shows even moderate alcohol consumption associated with increased cancer risk 2Health News:Goserelin improves long-term survival in premenopausal women with early breast cancer 2Health News:Cardiologists initiate STILETTO study to investigate treatment options for women with chest pain 2Health News:Stroke treated significantly faster and just as safely by medical residents 2Health News:Stroke treated significantly faster and just as safely by medical residents 3Health News:Diabetes a risk factor for postpartum depression 2
(Date:12/15/2009)... Dec. 15 Sonic Innovations, Inc. (Sonic), ... and solutions, donated $10,000 to its local Feeding ... 14, 2009. ,, Sonic Innovations President Paul Wennerholm ... America member, the Utah Food Bank, at the ... also participated in an office food drive and ...
(Date:12/15/2009)... DAYTON, Ohio, Dec. 15 Robbins & Myers, ... it will release results for its fiscal 2010 first ... on Wednesday, January 6, 2010. A live ... at 2:30 p.m., ET. Peter C. Wallace, ... Vice President and Chief Financial Officer, will be discussing ...
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
Breaking Medicine Technology:Sonic Innovations, Inc. Donates $10,000 to Feeding America 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 1BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 3Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 1Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 2FDA Launches Orphan Drug Workshop at KGI 6860 1FDA Launches Orphan Drug Workshop at KGI 6860 2
... File NDA in Second Quarter of 2008 -, ... WPI ), a leading specialty pharmaceutical,company, announced positive results ... (OTG) in patients with overactive bladder (OAB). The,study met ... episodes, and secondary endpoints of reduction in frequency,and increases ...
... Fovea Pharmaceuticals SA, which, last,December 2007, ... today announced that,its product, Recombinant human rod-derived ... Orphan Medicinal Product from the,European Commission, following ... the Evaluation of Medicinal Products (EMEA) Committee ...
Other Medicine Technology:Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 2Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 3Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 4Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 5Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The Pediatric ThermoWrap™ is designed to fit the proportions of your young patient and wraps around the entire body, without interfering with the sterilized area of operation....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The design of the large pediatric underbody blanket conveniently warms the large child or small adult patient while allowing full access for surgeons and staff....
Medicine Products: